Unpublished data from our laboratory suggests that intermediate and high-grade B-cell lymphomas tend to show increased expression of CD71 and likewise, the neoplastic cells of THRLBCL showed increased expression of CD71. Here, TFRC is linked to B-cell non-Hodgkin lymphoma.